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Abstract
The innate immune system is the first line of defense against inhaled particles. Macrophages serve important roles
in particle clearance and inflammatory reactions. Following recognition and internalization by phagocytes, particles
are taken up in vesicular phagolysosomes. Intracellular phagosomal leakage, redox unbalance and ionic movements
induced by toxic particles result in pro-IL-1β expression, inflammasome complex engagement, caspase-1 activation,
pro-IL-1β cleavage, biologically-active IL-1β release and finally inflammatory cell death termed pyroptosis. In this
review, we summarize the emerging signals and pathways involved in the expression, maturation and secretion of
IL-1β during these responses to particles. We also highlight physicochemical characteristics of particles (size, surface
and shape) which determine their capacity to induce inflammasome activation and IL-1β processing.
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Background
Interleukin-1β (IL-1β) is a highly active cytokine playing
an essential role in inflammation and tissue damage. An
abundant literature has depicted the details of IL-1β
regulation and functions during infectious and inflam-
matory diseases. Various IL-1β-targeting agents such as
IL-1 receptor antagonist, soluble decoy receptor and
neutralizing monoclonal anti-IL-1β antibody have been
used with success in several inflammatory diseases such
as rheumatisms, diabetes and cancers in humans [1, 2].
The different components of the IL-1β signaling path-
way have been largely elucidated and comprise the IL-1
type 1 receptor (IL-1RI), its co-receptor (IL-1RAcP) and
the adaptor molecule (MyD88). Research on IL-1β has
recently been revitalized by the discovery of the inflam-
masome machinery (constituted of the caspase-1 en-
zyme, ASC adaptor and NLRP sensor) which allows the
release of mature IL-1β from the immature and inactive
IL-1β pro-form. The transcription of the IL1B gene
encoding pro-IL1β results from the activation of the
transcription factors nuclear factor-kB (NFkB) and acti-
vator protein 1 (AP-1) [3, 4].
Intense research on the IL-1β/inflammasome axis has
resulted in new concepts of cell death pathways and re-
lated signaling cascades. Activated caspase-1 cleaves gas-
dermin D to induce a lytic cell death, termed pyroptosis
[5]. Pyroptosis represents a necrotic cell death that in-
duces cell swelling and plasma membrane rupture with
release of mature IL-1β and cytoplasmic content leading
to an inflammatory reaction. IL-1β processing is, however,
not specifically related to necrosis. Apoptosis-related
caspase-8 also binds to inflammasome complexes,
activates the NLRP3 inflammasome and processes IL-1β
to induce apoptotic cell death. Similarly, RIPK3- and
MLKL-dependent necroptotic signaling can activate the
NLRP3 inflammasome to drive IL-1β inflammatory re-
sponses [5–7]. These findings strongly support the intim-
ate interrelation of IL-1β processing and cell death.
Finally, IL-1β release can occur independently of cas-
pase1/inflammasome pathway through cleavage mecha-
nisms related to cathepsins [8–10].
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Interestingly, very early research on IL-1β revealed
that monocyte-derived macrophages or tissue macro-
phages exposed to silica or asbestos particles strongly re-
lease IL-1β. Particle-induced inflammasome activation,
IL-1β release and pyroptosis are still mostly described in
macrophages and the exact cellular mechanisms that re-
sult in IL-1β processing after exposure to cytotoxic
doses of particles have been mainly discovered in macro-
phages. However, other immune cells such as dendritic
cells or monocytes are also able to release large amount
of mature IL-1β. In addition, structural cells of various
body compartments exposed to particles secrete, al-
though to a lesser extent, mature IL-1β [11–18]. For
instance, primary rat epithelial lung cells, cardiomyo-
cytes, cardiofibroblasts and mesothelial cells also
respond to particles by priming and activating inflam-
masome [13, 16, 19–21]. It remains however to explore
whether the mechanisms of inflammasome activation
and IL-1β maturation in these cells correspond to those
defined in macrophages.
A major role of mature IL-1β in asbestosis and silicosis
was proposed more than 30 years ago [22–24]. It is now
well-established that active IL-1β serves as a primary ini-
tiating signal to coordinate the mobilization of immune
cells to the damaged area caused by particles. Seminal
studies in lung toxicology showed that IL-1β produced
by particle-exposed macrophages induces, in concert
with TNF-α, the production of chemokines by epithelial
cells and mediates particle-induced neutrophil and
macrophage influx and subsequent inflammatory lung
responses [25–27]. The exact in vivo role of IL-1β in the
development of chronic inflammation, fibrosis and can-
cer induced by particles has been reviewed in recent
publications [28–31].
This review summarizes current knowledge on the
main cellular signals responsible for the release of ma-
ture IL-1β after particle exposure. We first recapitulate
the endogenous mediators (called signal 1) that prime
the expression of the inactive pro-form of IL-1β (pro-IL-
1β) by macrophages during the early response to parti-
cles. The second part delineates the intracellular events
induced by particles (called signal 2) that result in
NLRP3 inflammasome activation and IL-1β processing
in macrophages. Finally, we highlight the physicochemi-
cal features of the particles which determine IL-1β
processing.
Priming cells to express pro-IL-1β: the role of alarmins
and inflammatory cytokines
Activation of the IL-1 pathway requires first signals
which comprise priming molecules inducing the tran-
scription of pro-IL-1β through the NFkB/AP-1 signal
transduction axis (signal 1). A variety of danger signals,
also called alarmins, have been recognized as the first
inflammatory signal elements strongly inducing pro-IL-
1β expression. These molecules are usually sequestered
inside homeostatic cells but released in the extracellular
environment when the cell membrane is corrupted dur-
ing necrosis, pyroptosis or if apoptotic bodies are not
rapidly cleared and release their cytoplasmic content
(secondary necrosis) (reviewed in [32]). The cytokines
IL-1α, IL-33 and HMGB1 as well as certain heat shock
(HSP) or S100 proteins are considered as potent alar-
mins during inflammation or immune responses to
pathogens. They bind membrane receptors and trigger
inflammatory pathways leading to NFkB or AP-1 activa-
tion and pro-IL-1β gene transcription. Besides alarmins,
it is well known that IL-1β itself and TNF-α, another
master pro-inflammatory cytokine, which are rapidly re-
leased by macrophages after exposure to particles, are
considered as crucial priming factors (see Fig. 1).
1. Interleukin-1α
Expression of IL-1α is constitutive in diverse cells
types in relation to the NFkB/AP-1 activation pathway
(reviewed in [33, 34]). Akin IL-β, IL-1α is produced
as a precursor. However, this pro-form is active and
can bind IL-1RI to induce the production of inflam-
matory molecules. IL-1α lacks a secretory sequence
signal and is released by an unconventional secretory
pathway by simple diffusion across cell membrane
upon membrane damage and necrosis or upon
inflammasome activation. Several studies investigated
IL-1α release in response to particles in LPS-primed
cells [12, 35–37]. Less well described is the release of
constitutive IL-1α cellular content. Primary rat lung
epithelial cells exposed to ultrafine carbon black re-
leased IL-1α independently of a concomitant gene ex-
pression. The release of IL-1α preceded and amplified
the production of other pro-inflammatory molecules
such as IL-6 [16].
Fine (PM2.5) and, to a lesser extent, coarse particu-
lates (PM10) from urban atmosphere induced IL-1α
release from human bronchial epithelial cell line
(BEAS-2B) [38]. We observed that IL-1α was released
from cellular stocks present in primary macrophages
or a macrophage cell line after exposure to silica or
carbon nanotubes (CNT). Importantly, IL-1β release
and neutrophil recruitment in the lung response to
silica instillation were strongly reduced when mice re-
ceived IL-1α neutralizing antibodies or in IL-1α-
deficient mice [39, 40]. Similarly, IL-1β release in the
peritoneal cavity following monosodium urate (MSU)
injection was reduced in IL-1α-deficient mice [35].
These findings strongly support the view that IL-1α
represents a major early signal released after particle
exposure that allows the expression of IL-1β.
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2. HMGB1
HMGB1 is constitutively expressed in all cells and can
be released following cell necrosis or secreted by acti-
vated immune cells. Extracellular HMGB1, alone or
complexed to other pro-inflammatory molecules can
bind the RAGE receptor or TLRs, trigger the NFkB and
AP-1 pathway and induce pro-inflammatory cytokine
production [41, 42]. Particle-induced HMGB1 release
has been documented in human macrophages and bron-
chial epithelial cell lines treated with silica or in
asbestos-exposed mesothelial cells [14, 20, 21]. Passive
and active release of HMGB1 has also been reported in
cultures of an epithelial cell line or primary alveolar
macrophages exposed to MWCNT [43]. The presence of
HMGB1 in the extracellular environment increased IL-
1β secretion by MWCNT-treated alveolar macrophages.
Interestingly, inhibition of extracellular HMGB1 by
neutralizing antibodies reduced MWCNT-induced IL-1β
secretion and inflammation in vivo [43]. By using
RAGE-deficient mice, Ramsgaard and colleagues also
demonstrated that this receptor is involved in neutrophil
influx following silica lung exposure [44]. Thus, HMGB1
is an additional important alarmin that mediates the ex-
pression of IL-1β.
3. Interleukin-33
Interleukin-33, a cytokine of the interleukin-1 family,
is expressed by structural and inflammatory cells and, as
a pro-form or after maturation, activates its receptor
ST2 [45]. Similar to interleukin-1α and β, the precursor
of this interleukin can be matured upon cleavage by
several enzymes with different effects on its activity.
Cleavage by caspase-1, 7 or 8 inactivates IL-33 whereas
calpain and neutrophil- or mastocyte-derived proteases
have the opposite effect by enhancing the alarmin activ-
ity [46]. IL-33 release in response to particle exposure
has been reported in several studies. Alum has been
shown to induce IL-33 release from THP-1 macrophages
[47] and MWCNT induced IL-33 release in supernatant
of an epithelial cell line and in broncho-alveolar lavage
fluid of mice [48–51]. Although IL-33 is highly released
after particle exposure, it is still unclear whether IL-33 is
central to the induction of IL-1β expression after particle
treatment.
4. Other alarmins implicated in particle-induced
priming
S100A8/S100A9 proteins are constitutively expressed
by phagocytes and released by non-classical pathways or
by diffusion across cell membrane upon necrosis. Once
in the extracellular environment, these mediators bind
TLR4 or RAGE and activate the NFkB and AP-1
Fig. 1 Processes involved in particle-induced pro-IL-1β expression. Pro-IL-1β expression requires intermediary mediators (signal 1). Silica-damaged
macrophages or structural cells release intracellular proteins called alarmins that possess inflammatory activities once present in the extracellular
environment. HGMB1 (High mobility group box-1), S100 and HSP (Heat shock proteins) proteins bind to multi-ligand receptors such as RAGE
(Receptor for advanced glycation endproducts) or TLRs (Toll-like receptors) and stimulate the NFkB (transcription factors nuclear factor-kB)/AP-1
(Activator protein 1) pathway, leading to pro-IL-1β expression by surrounding macrophages. IL-1α and IL-33, two members of the IL-1 family, also
pass across damaged cell membranes and bind their specific receptors, IL-1RI and ST2 (Interleukin 1 receptor-like 1), respectively. Additionally,
other cytokines that are not classified as alarmins but known to promote pro-IL-1β production via NFkB/AP-1 activation (i.e., TNF-α and IL-1β itself)
also participate in the expression of pro-IL-1β and synergize with alarmins
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pathway (reviewed in [52, 53]). High levels of S100A8
and S100A9 were detected in BAL of rats exposed to
diesel exhaust or ZnO particles [54, 55] and in lung tis-
sue of mice exposed to SWCNT [56]. Heat shock pro-
tein (HSP) form a group of proteins that can bind
various types of receptors, activate NFkB and trigger
pro-inflammatory cytokine production ([57, 58] and
reviewed in [59]). HSP60 release and subsequent TLR4
engagement have been implicated in the production of
pro-IL-1β in monocytes exposed to polyethylene parti-
cles [60]. Despite their well-recognized role in sterile in-
flammation, S100 and HSP proteins have received little
attention for their possible implication in IL-1β priming
in the frame of particle-induced inflammation.
5. Other cytokines implicated in particle-induced
priming
IL-1β regulates its own gene expression since its recep-
tor IL-1RI is directly connected to the NFkB and AP-1
axis [61]. This suggests a possible autocrine loop in the
production of pro-IL-1β during responses to particles.
Interestingly, constitutive expression of pro-IL-1β has
already been described in non-immune cells [14, 62–64].
The maturation of this constitutive pro-IL-1β may result
from intracellular inflammasome mobilization or external
proteases after pro-IL-1β diffusion [65–67]. Kono and col-
leagues observed that while IL-1β was crucial in silica-
induced inflammatory response, caspase-1-deficient mice
demonstrated only a limited reduction of inflammatory
parameters in comparison to cathepsin C-deficient
mice. Cathepsin C is necessary for activating serine
proteases, and the authors postulated that its absence
impaired extracellular IL-1β activation mediated by
these proteases [8].
TNF-α is a powerful activator of NFkB/AP-1 and is
known to induce IL-1β expression [68]. Under resting
conditions, TNF-α translation is repressed in most cells
[69] but rapidly restored under stress conditions [70]. In
addition, a membrane-bound precursor of TNF-α can be
processed by a TNF-α converting enzyme (TACE) to
promptly generate secreted mature TNF-α [71]. Thus,
TNF-α can be rapidly produced and released, independ-
ently of transcriptional induction, and can mediate early
pro-IL-1β production. Release of TNF-α has been shown
in response to different types of particles such as titan-
ium nanoparticles, carbon nanotubes, polymethylmetha-
crylate particles, PM10 ambient particulate matter, wood
smoke and traffic particles in vitro or in vivo [72–77].
Inhibition of TNF-α by a neutralizing antibody has been
shown to reduce IL-1β production by A549 cells and hu-
man bronchial epithelial cells exposed to urban PM10
[75]. Interestingly, TNF-α promotes caspase-1 activation
in response to silica [78].
Thus even if they are not considered to be constitu-
tively expressed and stored such as classical alarmins,
early release of IL-1β and TNF-α are involved in the
priming step that allows immune cells to produce high
amounts of IL-1β.
Signals and mechanisms implicated in inflammasome
processing of IL-1β in response to particles
The inflammasome is a multimeric complex mainly consti-
tuted by a sensor protein, the adapter protein Apoptosis-
associated Speck-like protein containing CARD (ASC), and
the cysteine protease caspase-1. Detection of a stimulus
triggers a conformational change of sensor protein that
leads to its oligomerization, recruitment of ASC through
homotypic protein–protein interactions of the pyrin do-
mains and subsequent recruitment and auto-activation of
caspase-1, which in turn cleaves pro-IL-1β into its mature
form [79]. NLPR3 is the sensor protein that has been
mostly investigated in the context of particle-induced re-
sponses. NLRP3 is predominantly expressed in macro-
phages. NLRP3 inflammasome activation (also termed
assembly or engagement) was first demonstrated by using
MSU and calcium pyrophosphate dihydrate (CPPD) crys-
tals [80]. Subsequently, a plethora of studies confirmed that
diverse inflammatory particles are able to activate the
NLRP3-inflammasome machinery. However, it appeared
obvious that the NLRP3-protein complex cannot be dir-
ectly triggered by particles themselves. Intensive investiga-
tions exploring indirect cellular events (signal 2) have led
to propose at least four main processes accounting for
inflammasome activation in response to particles: (1) lyso-
somal damage and subsequent lysosome content release,
(2) modifications of intracellular ionic concentrations and
localization, (3) intracellular redox unbalance and (4)
organelle damage (summarized in Fig. 2).
1. Critical role of lysosomal damage
Endocytosis
The importance of endocytosis for particle-induced
inflammasome engagement has been first demonstrated
by using the actin polymerization inhibitors cytochalasin
or lactrunculin in mononuclear and dendritic cells ex-
posed to silica particles [81–84]. The essential role of
actin-mediated endocytosis was further robustly estab-
lished in response to various particles such as aluminum
salt-constituted [36, 81, 85, 86], titanium dioxide (TiO2)
[87] or polymeric particles [36, 88, 89] and asbestos or
CNT fiber-shaped particles [90, 91]. However, cellular
uptake of particles is not an obligatory step for the pro-
cessing and the secretion of IL-1β after particle expos-
ure. Indeed, a direct contact between particles and the
cell membrane can be sufficient for activating the
inflammasome complex in macrophages or dendritic
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cells. Macrophages significantly released IL-1β even if
they were exposed to non-phagocytozed polymethyl-
methacrylate microspheres or MSU crystals [92, 93]. In
addition, cell contact of non-phagocytable polystyrene
beads [36] or surface-glued alum crystals also resulted in
IL-1β secretion by dendritic cells without internalization
[94]. In comparison with internalized particles, cell
membrane-associated silica highly induced IL-1β release
by macrophages [95]. Finally, lipid raft formation at cell
membrane surface also leads to IL-1β secretion in re-
sponse to large polymeric particles [92].
Thus, it appears that particle recognition and/or endo-
cytosis are competent to cause inflammasome and IL-1β
processing.
Damage to lysosome
Lysosomal rupture, induced by soluble destabilizing
agents such as L-leucyl-L-leucine methyl ester (Leu-Leu-
OMe), is sufficient for inflammasome activation [84]. A
clear correlation has also been found between the lysoso-
molytic ability of particles and inflammasome activation po-
tency. Silica particles accountable for a robust lysosomal
Fig. 2 Cellular signals responsible for particle-induced inflammasome activation. Inflammasome activation after particle exposure results from
various intracellular events (called signal 2) that are non-mutually exclusive. When endocytosed, nano- and micrometric-particles or exogenous
NLRP3 complexes induce lysosomal destabilization and interfere with autophagy/mitophagy resulting in the release of ROS (Reactive oxygen
species), cathepsins (Cat) or calcium in the cytosol. These vesicular leaking molecules promote the assembly of inflammasome components
(NLRP3/ASC/Caspase-1) and subsequent IL-1β maturation from inactive pro-IL-1β form. Oxidative stress and active cathepsins modify undetermined
protein structures which are recognized by the NLRP3 inflammasome. High calcium concentrations due to lysosomal but also endoplasmic reticulum
release or extracellular influx via TRP (Transient receptor potential) calcium-channels affect mitochondria which release high amount of ROS. TAK1
(Tat-associated kinase), a kinase activated by increased intracellular calcium, is also implicated in inflammasome processing. Depletion in intracellular
potassium is mandatory for inflammasome activation. Potassium cell efflux is indeed a necessary and sufficient signal for inflammasome activation and
IL-1β processing. ATP release upon cell membrane damage permeates P2X7R (P2X purinoceptor 7) channels to potassium. Particle endocytosis is not
systematically required and contact between cell membrane and particles resulting in the formation of lipid rafts is sufficient to trigger inflammasome
engagement through SYK (Spleen tyrosine kinase) activation. The small size of nanoparticles allows them to cross biological membranes. Nanoparticles
reach the cytosol even in absence of active endocytic process and may damage organelles such as mitochondria. Water movements through AQP
(Aquaporin) 1 are necessary for inflammasome activation. Water channels are involved in inflammasome by regulating cytoskeleton rearrangement,
ionic movements and TRP activation
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destabilization induced IL-1β secretion [82, 96]. Implication
of lysosomal leakage in inflammasome mobilization is now
demonstrated in response to diverse silica particles in mac-
rophages [82, 83, 95, 97] or dendritic cells [36]. Interest-
ingly, the in vitro membranolytic activity of silica
particles on red blood cells predicts the labilization of
the phagolysosome, the activation of inflammasome
and release of IL-1β [98].
Particles are endocytosed in vesicular phagosomes which
then undergo fusion with lysosomes, forming phagolyso-
somes. The fusion of particle-containing vesicles with lyso-
somes leads to acidification and ROS production in an
attempt to digest particles. Both biological processes can be
implicated in lysosomal destabilization and inflammasome
activation. Indeed, inhibition of endosomal acidification by
bafilomycin A1 successfully reduced lysosomal leakage and
the subsequent IL-1β production in macrophages or den-
dritic cells exposed to silica, titanium, alum or polymeric
particles [36, 82–84, 87, 97]. Also, pretreatment of silica-
exposed macrophages with the ROS scavenger butyl-
ated hydroxyanisole (BHA) strongly reduced endoso-
mal rupture and subsequent IL-1β release [83].
Cytosolic leakage of cathepsin B after lysosomal dam-
age also causes NLRP3 activation. The CA-074-Me ca-
thepsin B inhibitor strongly affects IL-1β maturation
induced by several fibrous and non-fibrous particles such
as silica [35, 81, 83, 84, 97], titanium [12, 35, 87, 99],
aluminum [36, 81, 85] or polymeric particles [36, 88], as-
bestos or CNT [37, 100]. However, the role of cathepsin B
in particle-induced inflammasome activation is still a mat-
ter of debate. Indeed, cathepsin B-deficient bone marrow-
derived macrophages (BMDMs) did not secrete less IL-1β
and did not cleave caspase-1 less than WT cells in
response to alum or silica [90, 93]. Similarly, cathepsin B
deficiency did not reduce IL-1β release induced by lipo-
somes in BMDM cultures whereas a cathepsin B inhibitor
did [101]. This discrepancy could be explained by the lack
of specificity of cathepsin inhibitors used in vitro or by the
redundancy between cathepsins [102]. How cathepsin re-
lease could be implicated in caspase-1 and inflammasome
activation is also not clear. Cathepsin B can directly
process pro-caspase-1 [103] but a general intracellular
protein degradation caused by cathepsin B release, that in
turn induces caspase-1 activation, represents a more prob-
able mechanism. In particular, cathepsin B leakage is also
involved in mitochondrial damage [104] or potassium
efflux [86], two processes that are mandatory in inflamma-
some activation (see below).
Finally, the lysosome contains high concentrations of
ions and their release upon lysosomal membrane
damage may also explain inflammasome activation. In
particular, lysosomal damage and leakage can lead to
deleterious cytosolic calcium concentrations and inflam-
masome activation [105].
In conclusion, particle-induced lysosomal damages in-
duce multiple cellular perturbations that combine to
maximize inflammasome activation in response to
particles.
Autophagy
Lysosomal functions are not limited to digestion of
endocytosed materials but also concern endogenous ma-
terial elimination by a process called autophagy [106].
Autophagy is necessary to degrade and recycle damaged
proteins and organelles, such as mitochondria. Inhibition
of autophagy/mitophagy induces accumulation of ROS-
generating damaged mitochondria and potentiates IL-1β
processing in response to MSU crystals and soluble
nigericin [107]. Particles impair normal autophagolyso-
some formation and induce inflammasome activation by
the following events [106]. First, accumulation of non-
destructible particles in phagolysosome leads to lyso-
some overload and prevents their fusion with autopha-
gosomes [108]. Secondly, once in the cytosol, particles
can bind to actin and impair cytoskeleton remodeling
that is necessary for maturation and function of the
autophagosome [109]. Finally, particles present in the
cytosol can diffuse through the membrane and be in-
corporated in autophagic vesicles leading to their
destabilization. For instance, nanoparticles can be in-
corporated to autophagic vesicles when ubiquitinated
or associated with ubiquitinated proteins [110].
Altogether, these recent observations support the view
that particles impair proper autophagic processes, favor-




Reduced intracellular potassium concentration is
mandatory for inflammasome activation. Reduction of
intracellular potassium level induces a conformational
change of NLRP3 allowing its activation [86, 111]. Add-
itionally, potassium efflux could cause disruption of
mitochondrial membrane potential [112] or ROS pro-
duction [113]. Potassium efflux has been observed in
response to silica exposure before IL-1β release and
its inhibition reduced IL-1β and caspase-1 activation
in response to silica, alum, silver or polymeric parti-
cles, asbestos or CNT in macrophages or dendritic
cells [35, 36, 86, 89, 91, 101, 114–117]. How particle
exposure leads to potassium efflux is still unknown. It
has been suggested that plasma membrane damages
or distortions caused by particle contact with cell sur-
face may explain cellular potassium leakage. Activa-
tion of the P2X7R cation-channel in response to ATP
binding has also been implicated in particle-induced
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potassium efflux and inflammasome activation. Riteau
and colleagues demonstrated that following silica or
alum phagocytosis and subsequent lysosomal leakage,
cellular ATP is released in the extracellular environ-
ment where it can bind to P2X7R and activate the
inflammasome [118]. IL-1β release in response to
latex beads was also reduced in presence of apyrase (ATP
diphosphohydrolase) or in P2X7R-deficient macrophages
[89]. However, the implication of ATP and P2X7R in po-
tassium efflux in the context of inhaled particles remains
controversial since silica-induced IL-1β release by macro-
phages was not reduced by apyrase nor deficiency in
P2X7R in other studies [117, 119, 120]. Thus, the exact
mechanism by which potassium is released by particle-
exposed cells still needs to be determined. Adenosine re-
leased by particle-exposed macrophages also activates the
NLRP3 inflammasome by interacting with adenosine
receptors and through cellular uptake by nucleoside trans-
porters [121].
Calcium
While potassium efflux is a necessary and sufficient
signal, modification of free cytosolic calcium concentra-
tions has also been implicated in inflammasome activa-
tion in response to soluble activators [105, 122]. Few
studies have investigated calcium modifications in cells
exposed to particles and the role of this ion in inflamma-
some activation remains uncertain. It has been shown
that alum crystals induce calcium mobilization from the
endoplasmic reticulum that is required for NLRP3
inflammasome activation in BMDM cells [105]. Extracel-
lular calcium influx also affects intracellular calcium
balance. Exposure to silica and alum increased free cyto-
solic calcium concentration by an extracellular entry
through ROS-activated TRPM2 channel (Transient re-
ceptor potential cation channel, subfamily M, member
2). Reduction of this influx by lowering extracellular cal-
cium or suppressing TRPM2 channels leads to a partial
decrease of IL-1β secretion [101, 105]. Calcium is impli-
cated in multiple cellular functions and probably impacts
the particle-induced inflammasome activation process at
different levels. Indeed, actin polymerization and
organelle trafficking necessary for phagolysosomal mat-
uration are dependent of intracellular calcium move-
ments. Thus, increased concentration of calcium could
impact particle uptake and subsequent lysosomal dam-
age. Potassium efflux necessary for inflammasome
activation is also triggered by the activation of calcium-
dependent potassium channels when cytosolic calcium
concentrations are increased [123]. Finally, high levels
of cellular calcium also induce mitochondrial dysfunc-
tion or trigger activation of TGF-β-activated kinase 1
(TAK1), both associated with inflammasome activation
[105, 111].
In conclusion, it is probable that alteration of intracel-
lular calcium homeostasis is involved in particle-induced
inflammasome mobilization. However, the elucidation of
the mechanism leading to this ionic dysregulation needs
future investigations in cells exposed to particles.
3. Oxidative stress
Increased cellular production of ROS has been ob-
served in response to most inflammasome activators.
Interestingly, silica-induced ROS production was de-
tected even in NLRP3-deficient macrophages, indicating
that ROS production is upstream of inflammasome
activation [114]. The use of ROS scavengers such as N-
acetylcysteine or ebselen, a glutathione peroxidase
mimic, efficiently reduced IL-1β release and caspase-1
activation in response to particles such as silica, alum or
asbestos in dendritic or mesothelial cells [19, 35] and the
deficiency in the ROS detoxifying protein thioredoxin
(TRX) increased IL-1β maturation induced by silica and
asbestos in macrophage cell lines [115]. TRX overex-
pression or treatment with recombinant TRX attenuated
caspase-1 enzymatic activity and secretion of IL-1β in
silica-exposed epithelial cell or macrophage cultures
[124]. These data convincingly demonstrate that ROS
production is a crucial event in inflammasome process-
ing in response to particles.
In addition to ROS produced intrinsically by the parti-
cles themselves, the NADPH oxidase pathway and the
damaged mitochondria also lead to intracellular ROS
production. Upon particle phagocytosis, phagosome-
associated NADPH oxidase produces ROS that could be
released in the cytosol upon lysosomal leakage. Inhibition
of NADPH oxidase by ROS inhibitors such as diphenyle-
neiodonium (DPI), ammonium pyrrolidinedithiocarba-
mate (APDC) or apocynin reduced IL-1β secretion or
caspase-1 activation in response to silica, asbestos, CNT
or titanium particles [37, 83, 87, 90, 101, 114, 115, 125].
The use of mice deficient in essential components of the
membrane-associated phagocyte NADPH oxidase led,
however, to confusing results. Cells lacking the
p22phox expression had reduced inflammasome activa-
tion in response to asbestos whereas deficiency in
gp91phox did not modify silica-induced inflammasome
activation [84, 90, 115]. Interestingly, mitochondrial
ROS production during inflammasome activation has
also been demonstrated after silica and alum treatment in
macrophages [85, 125]. Altogether, these studies indicate
that the enzymatic and cellular pathways leading to ROS-
induced inflammasome activation are diverse and might
depend on particle physicochemical properties.
How ROS activate NLRP3 is still debated but it is postu-
lated that proteins modified by oxidative stress directly
bind NLRP3. The complex formed by the ROS detoxifying
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protein thioredoxin (TRX) and thioredoxin-interacting
protein (TXNIP) has also been proposed to link ROS and
NLRP3 activation. Under normal conditions, TXNIP is as-
sociated with TRX. However, the presence of free radicals
oxidizes TRX that cannot bind TXNIP anymore. TXNIP
then interacts with and activates NLRP3. TXNIP defi-
ciency in antigen-presenting cells reduced caspase-1 acti-
vation and IL-1β release induced by silica, asbestos and
alum [19, 107, 115]. The absence of TXNIP has also been
shown to prevent IL-1β release in a model of MSU-
induced peritonitis [107]. However, two studies failed to
confirm requirement of TXNIP for inflammasome acti-
vation in response to silica and latex beads in BMDM
[89, 126]. Finally, there is evidence that the sources of
ROS are multiple and interconnected. Indeed, ROS re-
leased by particles or phagolysosomes directly or indir-
ectly activate mitochondria to produce ROS. This
amplification loop of free radical generation may ex-
plain why anti-oxidant cell defenses are supplanted
after particle exposure and that the subsequent oxida-
tive stress generated in cells activates inflammasome
machinery.
4. Organelle damage
Mitochondrial damage has been proposed as an im-
portant event in NLRP3 inflammasome activation in
response to soluble activators [107, 125] and has been
associated with particle-induced inflammasome activa-
tion [89, 95, 116, 127]. Cathepsins, ROS and calcium
release after lysosomal leakage participate to the
mitochondrial damage induced by particles [104, 128].
Additionally, particles present in the cytosol after dif-
fusion or lysosomal escape may directly affect normal
mitochondrial function which may result in inflamma-
some activation [116]. Inhibition of damaged mito-
chondria clearance in BMDM exposed to latex beads
leads to increased IL-1β release, probably due to un-
controlled ROS release [89]. Under resting conditions
NLRP3 localizes to endoplasmic reticulum (ER) struc-
tures in THP-1 macrophages but upon exposure to
inflammasome-activating crystals such as alum,
NLRP3/ER complexes and ASC are relocalized to
mitochondria. Authors proposed that mitochondria
recruit inflammasome components and favor their
interactions. Additionally, voltage-dependent anion-
selective channel protein 1 (VDAC1), a channel
present at the mitochondrial membrane and control-
ling calcium transfer from ER, was implicated in
caspase-1 activation and IL-1β release in response to
silica and alum, possibly via ROS production [107].
Finally, cardiolipin, a mitochondrial-specific phospho-
lipid, translocates from the inner to the outer mito-
chondrial membrane and binds NLRP3, explaining
why inflammasome co-localizes with mitochondria.
This interaction then leads to caspase-1-mediated IL-
1β cleavage [125].
5. New mechanisms of particles-induced inflamma-
some activation
Macrophage swelling and subsequent regulatory vol-
ume decrease have been associated with NLRP3 inflam-
masome activation and IL-1β maturation in response to
different stimuli [35, 111, 129]. Interestingly, cell volume
modifications have been reported in the past in response
to particle endocytosis [37, 130, 131]. Recently, we dem-
onstrated that water movements through aquaporin
(AQP), in particular AQP1, are necessary for inflamma-
some activation in response to particles in murine mac-
rophages. AQP is implicated in swelling and shrinkage
of the cell to restore its homeostatic volume [132]. Sev-
eral mechanisms could explain the role of AQP in
inflammasome mobilization. AQP mediates cytoskeleton
rearrangement [133] necessary for particle endocytosis,
intracellular vesicular trafficking and inflammasome com-
ponents localization with filamentous actin [134–136].
The reduction of AQP-controlled water flux and volume
alterations probably affect potassium and calcium move-
ments which are necessary for particle-induced inflamma-
some activation. AQP could be necessary for calcium-
channel TRP activation [137, 138].
The ubiquitination process allows addressing protein to
the proteasome for their elimination, and regulates inflam-
masome activity by targeting the degradation of inflamma-
some components by autophagy [139]. For instance,
NLRP3 ubiquitination reduced inflammasome activation
in response to various activators such as silica crystals
[140]. On the other hand, it has been shown that the lin-
ear ubiquitination of ASC is necessary for silica-induced
inflammasome activation in BMDM cells [141]. Ubiquiti-
nation may thus repress or promote the particle-induced
inflammasome machinery according to the ubiquitinated
protein and ubiquitination process considered.
Various kinases have been implicated in the path-
way leading to IL-1β secretion after particle exposure
[16, 35, 142, 143]. In particular, Spleen tyrosine kinase
(SYK), a kinase regulating endocytosis and actin re-
modeling processes, has been involved in inflammasome
activation in response to polymeric particles, silica, alum,
asbestos and carbon nanotubes [37, 81, 92, 94]. In den-
dritic cells, contact between cell membrane and uric crys-
tals results in membrane lipid alteration that induces
activation of SYK and inflammasome activation [92, 94].
TAK1, a kinase involved in TLR signaling and activated by
intracellular Ca2+ variations, has also been involved in
inflammasome processing in response to ATP and os-
motic stress [111, 144]. Interestingly, this kinase has also
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been involved in inflammasome processing consecutive to
lysosomal rupture induced by Leu-Leu-OMe or uric crys-
tals [145]. The GTPase effector Rho-kinases (ROCK1, and
2) regulating cytoskeleton and phagocytosis have also been
involved in fibrous particle-induced inflammasome re-
sponses in THP-1 cells [146].
Recently, different groups demonstrated that inflamma-
some activation leads to the release of ASC and NLRP3
that form functional oligomeric inflammasome particles.
These complexes can be subsequently phagocytized by
surrounding macrophages and trigger lysosomal damage
and inflammasome activation. Additionally, ASC-NLRP3
complexes also form functional inflammasomes in by-
stander macrophages after being internalized [147–149].
Physicochemical characteristics of particles determining
inflammasome activation
Contrary to water soluble agents, the toxicity of particles
cannot solely be determined by chemical composition
and molecular structure. Various characteristics such as
(1) size, (2) surface curvature and (3) surface area or
shape strongly affect particle internalization, intracellular
localization, cell responses and IL-1β processing. A sum-
mary of studies considering the influence of particle
characteristics on inflammasome activation and IL-1β
release is provided in Tables 1, 2 and 3.
1. Size
Particle size is decisive for the processing and release
of biologically-active IL-1β by phagocytic cells. This no-
tion results from recent studies showing that nanoparti-
cles possess a strong capacity to induce IL-1β release.
BMDM exposed to amorphous silica nanoparticles with
size ranging from 30 nm to 10 μm released more IL-1β
in response to the smallest particles (30–1000 nm >
3 μm> 10 μm, when compared on a mass-based dose).
Lysosomal damage and not internalization or actin
polymerization explained these size-related differences
[82]. Another study confirmed that, when compared on
a mass-based dose, nanometric amorphous silica parti-
cles induced more IL-1β release by macrophages than








Identified mechanisms Cell type Reference
Amorphous silica
(100–1000 μg/ml)
20 295 ++++ Lysosomal acidification and cathepsin B activity Macrophages [97]
67 91 +++ Lysosomal acidification and cathepsin B activity
369 531 ++ N.a.
500 - 10000 342 - 5560 + Lysosomal acidification and cathepsin B activity
30 / ++++ Actin-mediated endocytosis and lysosomal acidification Macrophages [82]
100 / +++ Actin-mediated endocytosis and lysosomal acidification
300 / +++ Actin-mediated endocytosis and lysosomal acidification
1000 / +++ Actin-mediated endocytosis and lysosomal acidification
3000 / ++ Actin-mediated endocytosis and lysosomal acidification
10000 / +/− Lysosomal acidification
Carbon black
(62–687 μg/ml)
53,7 235 ++ N.a. Monocytes [165]
525 636 + N.a.
14 / ++ N.a. Monocytes [166]
260 / - N.a.
Silver
(0.15 – 0.9 μg/ml)
5 / ++ Potassium efflux and oxydative stress Monocytes [116]
28 / + Potassium efflux and oxydative stress
100 / - N.a.
Polystyrene
(120 – 3000 μg/ml)
1000 / ++++ N.a. Dendritic cells [36]
430 / +++ Actin-mediated endocytosis, lysosomal acidification
cathepsin B activity and potassium efflux
10 000 / ++ N.a.
32 000 / + N.a.
The smallest and fiber- or needle-like particles are particularly active to induce IL-1β release. Surface area properties and reactivity also govern inflammasome/IL-1β
activation. Physical or chemical treatments aiming to reduce surface reactivity can control inflammogenicity of particles
N.a. not assessed, N.r. not relevant
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their submicrometric counterparts (50 nm vs 500 nm)
[97]. BMDM and primary glial cells exposed to similar
mass doses of latex beads released more IL-1β in re-
sponse to 20 nm than 1 μm size particles. In this study,
inflammasome activation was attributed to lysosomal
destabilization and cathepsin B release for 20 nm parti-
cles and to ROS production and mitochondrial damage
for 1 μm particles. Additionally, inflammasome activa-
tion by the 20 nm particles was associated with their
capacity to induce cellular damage and ATP release [89].
In dendritic cells, IL-1β release after polystyrene particle
exposure (mass dose) was higher in response to 430 nm
and 1 μm than to the 10 or 32 μm particles. In this
model, small polystyrene particles were more efficiently
internalized in comparison with larger particles [36]. Sil-
ver nanoparticles of 5, 28 and 100 nm were all internal-
ized in monocytes but only 5 and 28 nm induced
vesicular damage with ROS production and IL-1β release
[116]. The relatively low capacity of micrometric
particles to activate the inflammasome appears related
with a lower endocytosis and lysosomal damage. It is
also important to emphasize that the small size of nano-
particles allows them to reach intracellular compart-
ments such as mitochondria [150] or to bind proteins
such as actin [109]. Simple diffusion of nanomaterials
across the cell membrane can be sufficient to activate
inflammasome in keratinocytes [12].
Altogether, these data suggest that smallest particles
are more potent, on a mass-based dose, to activate
inflammasome in phagocytic cells.
There are, however, some reported exceptions: THP-1
cells failed to release IL-1β in response to amorphous
silica particles below 1 μm [83] and spherical polystyrene
particles of 7–8 μm induced inflammasome processing
in macrophages whereas 0.5 and 1 μm did not [88].
Long fiber-shaped carbon, TiO2 or CeO2 nanoparticles
induced more IL-1β release than shorter ones in macro-
phages [37, 151–153]. Importantly, the impact of particle











Identified mechanisms Cell type Reference
Amorphous silica
(50–200 μg/ml)
Midly - + ++ Actin-mediated endocytosis, lysosomal acidification
and cathepsin B activity, oxidative stress
Macrophages [83]
- (−COOH) / + Actin-mediated endocytosis, lysosomal acidification
and cathepsin B activity, oxidative stress
+ (−NH2) / - N. r.
Silanol +++ +++ +++ N.a. Macrophages [95]
Silanol +++ ++ ++ Independent of entry and cathepsin B release
Silanol ++ + + N.a.
Silanol + + - N.r.
Polystyrene
(100 μg/ml)
+ (−NH2) / + Oxidative stress Macrophages [127]
- (−COOH) / - N.r.




OH- +++++ ++++ ++++ Actin-mediated endocytosis, lysosomal acidification




OH- ++++ +++ +++ Actin-mediated endocytosis and cathepsin B activity,
oxidative stress
OH- ++++ ++ ++ Actin-mediated endocytosis and cathepsin B activity,
oxidative stress
OH- ++ + + Actin-mediated endocytosis and cathepsin B activity,
oxidative stress
OH- + + +/− Oxidative stress (actin-mediated endocytosis and
cathepsin B activity not convincing)
MWCNT
(10–100 μg/ml)
Raw / +++ Lysosomal damage and cathepsin B activity Macrophages [100]
Purified (less Ni
contamination)
/ ++ Lysosomal damage and cathepsin B activity
- (−COOH) / + Cathepsin B activity
The smallest and fiber- or needle-like particles are particularly active to induce IL-1β release. Surface area properties and reactivity also govern inflammasome/IL-1β
activation. Physical or chemical treatments aiming to reduce surface reactivity can control inflammogenicity of particles
N.a. not assessed, N.r. not relevant
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size differs according to the cell type considered and
their endocytic capacities. In non-phagocytic cells such
as keratinocytes, only nanoparticles but not micrometric
particles are internalized and induce inflammasome ac-
tivity [12, 107].
Additionally, aggregation or agglomeration state of
particles (mainly nanoparticles) modifies particle diam-
eter, curvature, density, endocytosis and thus subsequent
inflammasome activation. Surface area available for par-
ticle reactivity can also be modified upon aggregation/
agglomeration (see below). Unfortunately, no study for-
mally and directly assessed the impact of aggregation on
IL-1β release. However, aluminum nanoplates and poly-
hedron of different aggregate sizes (hydrodynamic diam-
eter of 93 nm and 333 nm, respectively) but with similar
primary size, specific surface area and surface reactivity
induced similar level of inflammasome processing sug-
gesting minor impact of aggregation [85]. Our group
also demonstrated that aggregation in the nanorange did
not modify the cytotoxic effect of silica nanoparticles in
macrophages [154].
2. Surface area
On a mass basis, nanoparticles were frequently
claimed to be more cytotoxic, but, once normalized by
particle number or surface area, this difference was
blunted [155, 156]. This issue has also been addressed in
the frame of inflammasome activation. Expressed in mass
concentration, 50 nm amorphous silica particles induced
more IL-1β release than 500 nm in macrophages but
when dose was expressed in total surface area this trend
was reversed [97]. Similarly, differences in IL-1β levels re-
leased by BMDM in response to amorphous silica parti-
cles ranging from 30 to 1000 nm were dampened upon
normalization by particle number and almost abolished
once expressed in total surface area. However, in this
study, particles over 1 μm of diameter were less internal-
ized and macrophages released lower amounts of IL-1β
after surface area normalization [82]. Altogether, these
data suggest that surface area highly determines inflam-
masome activity of internalized particles.
Reactive groups present at particle surface can also
affect the ability of particles to induce inflammasome ac-
tivation. It is already known that silanol groups present
on the surface of silica particles are associated with their
toxic activity [157, 158]. Interestingly, reduction of




Shape Length/width (nm) (ratio) IL-1β
release
Identified mechanisms Cell type Reference
Titanium rutile
(20–500 μg/ml)
Spicula 40/10 (4) ++ Actin-mediated endocytosis,
lipid raft, lysosomal
acidification and cathepsin B
activity, oxidative stress
Macrophages [87]
Spheric 30-40 (≈1) + Actin-mediated endocytosis,
lipid raft, lysosomal




Spherical with budding N.r. ++ Actin-mediated endocytosis
and cathepsin B activity
Macrophages [88]
Spherical N.r. + Actin-mediated endocytosis
and Cathepsin B activity
Spherical N.r. - N.r.
Gold
(2–10 μg/ml)
Rod 40/10 (4) + N.a. Macrophages [164]
Spherical 40 (≈1) - N.a.
Cubic 40/40/40 (≈1) - N.a.
Carbon
(2–100 μg/ml)
Needle-like MWCNT 13 000/>50(<260) + Cathepsin B activity, oxydative
stress, src/syk pathway and
P2X7R activity
Macrophages [37]
Tangled MWCNT 10 000–50 000/8 – 15(667–6250) - N.r.
Short MWCNT 1000 - 10 000/0,5 - 20/(50–20000) - N.r.
Needle-like MWCNT 4150/150 (28) +++ Actin-mediated endocytosis Macrophages [163]
Needle-like HTCFNW 7600/586 (13) ++ N.a.
Needle-like HTCFNW 1800/365 (5) + Actin-mediated endocytosis
The smallest and fiber- or needle-like particles are particularly active to induce IL-1β release. Surface area properties and reactivity also govern inflammasome/IL-1β
activation. Physical or chemical treatments aiming to reduce surface reactivity can control inflammogenicity of particles
N.a. not assessed, N.r. not relevant
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silanol surface density by heating was associated with a
decreased IL-1β secretion by THP-1 cells. Subsequent
rehydration restored initial silanol concentration on par-
ticle surface together with IL-1β processing and release,
demonstrating their implication in inflammasome activa-
tion. However, in the same study, particles with similar
size, surface area and silanol characteristics but with dif-
ferent synthesis process presented different levels of
inflammasome activation capacity, probably in relation
with their ability to produce free radicals under acellular
conditions [95]. The hydroxyl surface amount also af-
fected IL-1β release in response to aluminum nanoparti-
cles in THP-1 cultures. Indeed, particle presenting
higher amounts of surface hydroxyl induced more
inflammasome processing. This effect was attributed by
the authors to an increased capacity of hydroxyl-rich
particles to induce ROS production and lysosomal dam-
age [85]. Surface metal contaminants can also exacerbate
IL-1β cleavage by catalyzing surface radical production
on particles. Chelation of iron reduced IL-1β maturation
after asbestos exposure probably by limiting oxidative
stress [115]. Oxidative dissolution of silver nanoparticles
upon lysosomal acidification leads to Ag ion release,
ROS byproducts, mitochondrial-derived ROS and ultim-
ately inflammasome activation in THP-1 cells [159, 160].
Nickel contamination was also implicated in CNT-
induced inflammasome activtion in mouse primary al-
veolar macrophages [161].
Importantly, functionalization of amorphous silica parti-
cles with various surface groups (−COOH, −NH2, −SO3H
and -CHO) reduced particle-induced IL-1β release by
THP-1 cells. These functionalizations reduced endosomal
rupture, cathepsin B leakage and ROS production by lim-
iting the access of surface silanol groups without affecting
particle uptake [83]. Carboxylic functionalization of
MWCNT completely inhibited IL-1β release by mac-
rophages after clearing nickel contaminant [100, 151].
Carboxylation of titanium nanobelts also reduced IL-
1β release by mouse alveolar macrophages and THP-1
cells, probably by reducing lysosomal damage [162].
Particle surface charge appears as another parameter
important for inflammasome processing. Polystyrene
beads induced lysosomal damage, cathepsin B release,
mitochondrial ROS production and IL-1β release solely
after amino-functionalization. Amino-functionalization in-
duced lysosomal destabilization consistent with the proton
sponge theory. The amine present at particle surface traps
protons. Consequently, proton pump activity is increased
and each proton that enters the lysosome is accompanied
by one chloride ion and one water molecule. This influx
of ions and water leads to lysosomal swelling and
destabilization as well as IL-1β release [127].
In conclusion, the surface reactivity determines the
ability of particles to induce lysosomal membrane
destabilization and inflammasome activation. This effect
results from the surface characteristics, chemical com-
position or contamination. Consequently, treatments al-
tering particle surface reactivity by eliminating reactive
groups or contaminants can be useful in order to reduce
particle inflammogenicity.
3. Shape
By affecting internalization and lysosomal stability, the
shape of particles is another important parameter which
determines the activity of particles on the inflammasome
machinery. In particular the high length/width ratio ap-
pears important in inflammasome activation by fibers.
Inert in THP-1 cells, CeO2 nanocubes or nanorods acti-
vate the inflammasome when their length is increased. In-
deed, these high length/width aspect ratio particles were
able to destabilize lysosomal membrane leading to cathep-
sin B release and subsequent inflammasome activation
[153]. Long TiO2 nanobelts induced more inflammasome
activation than short nanobelts and nanospheres in alveo-
lar macrophages. This activity was also linked to lysosomal
destabilization and cathepsin B release [152]. Similarly,
spiculated TiO2 particles induced stronger IL-1β release
by macrophages than spherical nanoparticles with similar
size [87]. Long well-dispersed carbon nanotubes as well as
needle-like calcined fullerene nanowhiskers (HTCFNW)
activate more intensively inflammasome than their shorter
counterpart [163]. Similarly, needle-like carbon nanotubes
are more active than spherical carbon black nanoparticles
and shorter nanotubes [37]. Among spherical and rod-
shaped gold nanoparticles in the same size range (20
and 40 nm diameter sphere and 10 nm witdh/40 nm
length rods), only rods were able to induce IL-1β re-
lease, even if all were endocytosed and both 20 nm
spheres and rods escaped lysosomes [164]. Curvature
is also an important particle characteristic for inflam-
masome activation. Spherical polymeric particles com-
posed of budding with combination of high positive
and negative surface curvature released more IL-1β
than smooth particles of the same size (7–8 μm).
This effect was correlated with the level of internal-
ized or associated budding particles [88].
Altogether, these data indicate that the shape of parti-
cles is also a major parameter determining particle-
induced inflammasome activation. Particles with an
aspect ratio close to one are particularly less efficient to
induce inflammasome activation than the longer ones.
Conclusions
After particle exposure, alarmins retained intracellularly
as preexisting stocks in lung resident cells and additional
early pro-inflammatory cytokines are released into the
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extracellular milieu. These first inflammatory mediators
(signal 1, Fig. 1) are potent activating stimuli required
for macrophages, meso- and epithelial cells to express
the biologically inactive precursor IL-1β (pro-IL-1β).
This form is subsequently cleaved by particle-induced
inflammasome activation prior its secretion as mature
and bioactive IL-1β.
The processes leading to inflammasome activation and
IL-1β maturation are initiated following lysosomal
destabilization and leakage of enzymes, ions or ROS
(signal 2, Fig. 2). These cellular events can result in
mitochondrial damage, crucial to NLRP3 and inflamma-
some activation. Physicochemical characteristics of parti-
cles such as size and shape are decisive for particle
internalization and lysosomal alteration. The smallest
and fiber- or needle-like particles are particularly active
to induce inflammasome activation. Surface area proper-
ties and reactivity also govern lysosomal damage and
subsequent inflammasome/IL-1β processing. Physical or
chemical treatments aiming to reduce surface reactivity
can control inflammogenicity of particles. Nanoparticles
can reach intracellular compartments and trigger meta-
bolic processes, and induce toxicity and inflammasome
activation by new pathways that are still to delineate.
The observation that diverse particles are able to activate
the inflammasome machinery allows considering the IL-
1-related machinery as a new and crucial pathogenic
pathway in particle toxicology.
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